TBC1D1 Antibody - #AF7908
(1)
(2)
| 製品: | TBC1D1 Antibody |
| カタログ: | AF7908 |
| タンパク質の説明: | Rabbit polyclonal antibody to TBC1D1 |
| アプリケーション: | WB |
| 反応性: | Human, Mouse |
| 分子量: | 133kDa; |
| ユニプロット: | Q60949 |
| RRID: | AB_2819093 |
製品説明
ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
反応性:
Human,Mouse
クローナリティ:
Polyclonal
特異性:
TBC1D1 Antibody detects endogenous levels of total TBC1D1.
RRID:
AB_2819093
引用形式: Affinity Biosciences Cat# AF7908, RRID:AB_2819093.
引用形式: Affinity Biosciences Cat# AF7908, RRID:AB_2819093.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:
折りたたみ／展開
KIAA1108; TBC 1; TBC; TBC1 (tre 2/USP6, BUB2, cdc16) domain family, member 1; TBC1; TBC1 domain family member 1; Tbc1d1; TBCD1_HUMAN;
免疫原
免疫原:
A synthesized peptide derived from mouse TBC1D1, corresponding to a region within the internal amino acids.
PTMs - Q60949 基板として
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| Y113 | Phosphorylation | Uniprot | |
| S145 | Phosphorylation | Uniprot | |
| S146 | Phosphorylation | Uniprot | |
| S163 | Phosphorylation | Uniprot | |
| S229 | Phosphorylation | Uniprot | |
| S231 | Phosphorylation | Uniprot | |
| S237 | Phosphorylation | Uniprot | |
| T253 | Phosphorylation | Uniprot | |
| S255 | Phosphorylation | Uniprot | |
| S256 | Phosphorylation | Uniprot | |
| S332 | Phosphorylation | Uniprot | |
| S336 | Phosphorylation | Uniprot | |
| S489 | Phosphorylation | Uniprot | |
| S497 | Phosphorylation | Uniprot | |
| T499 | Phosphorylation | Uniprot | |
| S501 | Phosphorylation | Uniprot | |
| S504 | Phosphorylation | Uniprot | |
| S519 | Phosphorylation | Uniprot | |
| S521 | Phosphorylation | Uniprot | |
| S559 | Phosphorylation | Uniprot | |
| S560 | Phosphorylation | Uniprot | |
| S564 | Phosphorylation | Uniprot | |
| S565 | Phosphorylation | Uniprot | |
| S567 | Phosphorylation | Uniprot | |
| S575 | Phosphorylation | Uniprot | |
| S579 | Phosphorylation | Uniprot | |
| T590 | Phosphorylation | P31750 (Akt1) | Uniprot |
| S592 | Phosphorylation | Uniprot | |
| S607 | Phosphorylation | Uniprot | |
| S608 | Phosphorylation | Uniprot | |
| S612 | Phosphorylation | Uniprot | |
| S621 | Phosphorylation | Uniprot | |
| S623 | Phosphorylation | Uniprot | |
| T624 | Phosphorylation | Uniprot | |
| S660 | Phosphorylation | Uniprot | |
| S661 | Phosphorylation | Uniprot | |
| K669 | Methylation | Uniprot | |
| S697 | Phosphorylation | Uniprot | |
| S698 | Phosphorylation | Uniprot | |
| S699 | Phosphorylation | Uniprot | |
| S700 | Phosphorylation | Uniprot | |
| T739 | Phosphorylation | Uniprot | |
| S747 | Phosphorylation | Uniprot | |
| S782 | Phosphorylation | Uniprot | |
| S1028 | Phosphorylation | Uniprot | |
| Y1039 | Phosphorylation | Uniprot | |
| K1179 | Ubiquitination | Uniprot | |
| T1218 | Phosphorylation | Uniprot | |
| S1237 | Phosphorylation | Uniprot | |
| S1241 | Phosphorylation | Uniprot | |
| T1242 | Phosphorylation | Uniprot |
参考文献
1). HWL-088, a new highly potent FFAR1 agonist, improves glucolipid metabolism and acts additively with Metformin in ob/ob diabetic mice. BRITISH JOURNAL OF PHARMACOLOGY, 2020
(PubMed: 31971610)
[IF=7.3]
Application: WB Species: mice Sample: liver
FIGURE 4 Effects of HWL-088 on plasma glucose levels (a) and corresponding AUC0–90min (b) of glucose during an OGTT in fasting ob/ob
mice. Tested agents or vehicle was orally administered to ob/ob mice twice daily for 30 days, and the OGTTs were determined on treatment days
1, 15, and 30. After long-term treatment, hepatic expression of genes involved in gluconeogenesis (c) and glycogen synthesis (d) as well as hepatic
expression of GSK3β (e). Effects of HWL-088 on the phosphorylation of AKT, AS160, and TBC1D1 in L6 myoblasts cells (f). Values are
mean ± SD (n = 6). *P ≤ .05 was analysed using a one-way ANOVA with Tukey's multiple-comparison post hoc test
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.